AstraZeneca Net Interest Income from 2010 to 2026

ZEGA Stock  EUR 75.50  0.00  0.00%   
AstraZeneca PLC's Net Interest Income is decreasing over the last several years with very volatile swings. Net Interest Income is predicted to flatten to about -1.4 B. Net Interest Income is the difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities. View All Fundamentals
 
Net Interest Income  
First Reported
2019-03-31
Previous Quarter
-349 M
Current Value
-349 M
Quarterly Volatility
28.2 M
 
Covid
 
Interest Hikes
Check AstraZeneca PLC financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AstraZeneca PLC's main balance sheet or income statement drivers, such as Interest Expense of 1.1 B, Selling General Administrative of 15.7 B or Total Revenue of 37.6 B, as well as many indicators such as . AstraZeneca financial statements analysis is a perfect complement when working with AstraZeneca PLC Valuation or Volatility modules.
  
This module can also supplement various AstraZeneca PLC Technical models . Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
The Net Interest Income trend for AstraZeneca PLC offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether AstraZeneca PLC is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest AstraZeneca PLC's Net Interest Income Growth Pattern

Below is the plot of the Net Interest Income of AstraZeneca PLC over the last few years. It is the difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities. AstraZeneca PLC's Net Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AstraZeneca PLC's overall financial position and show how it may be relating to other accounts over time.
Net Interest Income10 Years Trend
Very volatile
   Net Interest Income   
       Timeline  

AstraZeneca Net Interest Income Regression Statistics

Arithmetic Mean(1,292,688,235)
Coefficient Of Variation(3.44)
Mean Deviation33,507,958
Median(1,308,000,000)
Standard Deviation44,469,538
Sample Variance1977.5T
Range181.7M
R-Value(0.01)
Mean Square Error2109.2T
R-Squared0.0001
Significance0.97
Slope(89,706)
Total Sum of Squares31640.6T

AstraZeneca Net Interest Income History

2026-1.4 B
2025-1.3 B
2024-1.3 B
2023-1.3 B
2022-1.3 B
2021-1.3 B
2020-1.2 B

About AstraZeneca PLC Financial Statements

AstraZeneca PLC stakeholders use historical fundamental indicators, such as AstraZeneca PLC's Net Interest Income, to determine how well the company is positioned to perform in the future. Although AstraZeneca PLC investors may analyze each financial statement separately, they are all interrelated. For example, changes in AstraZeneca PLC's assets and liabilities are reflected in the revenues and expenses on AstraZeneca PLC's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in AstraZeneca PLC. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Interest Income-1.3 B-1.4 B

Currently Active Assets on Macroaxis

When determining whether AstraZeneca PLC offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AstraZeneca PLC's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Astrazeneca Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Astrazeneca Plc Stock:
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Please note, there is a significant difference between AstraZeneca PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if AstraZeneca PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, AstraZeneca PLC's market price signifies the transaction level at which participants voluntarily complete trades.